Visteon CORP Schedule 13G passive stakes

Vanguard Capital Management has reported beneficial ownership of 1,404,151 shares, representing 5.23% of Visteon Corp's common stock, as of March 31, 2026.

Vanguard Portfolio Management has reported beneficial ownership of 5.35% of Visteon Corp's common stock as of March 31, 2026.

Dimensional Fund Advisors LP has disclosed a beneficial ownership of 5.2% of Visteon Corp's common stock as of March 31, 2026.

The Vanguard Group has amended its Schedule 13G for Visteon Corp, reporting 0% beneficial ownership following an internal realignment.

American Century Investment Management, Inc. and affiliates report an 8.2% passive beneficial ownership stake in Visteon Corporation.

Victory Capital Management, Inc. has disclosed a 3.83% passive ownership stake in Visteon Corp., holding 1,044,633 shares of common stock.

American Century Investment Management, Inc., along with its affiliates, has filed an amended Schedule 13G, disclosing a 7.0% beneficial ownership stake in Visteon Corporation as of March 31, 2025.

Wellington Management Group LLP and its affiliates have filed an Amendment No. 6 to Schedule 13G, reporting a beneficial ownership of 3.9% of Visteon Corporation's common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 12.1% beneficial ownership stake in Visteon Corp as of March 31, 2025.

American Century Investment Management, Inc., along with its parent American Century Companies, Inc. and the Stowers Institute for Medical Research, has disclosed a passive beneficial ownership of 5.7% of Visteon Corporation's common stock as of December 31, 2024.

Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, disclosing a beneficial ownership of 6.1% of Visteon Corporation's common stock as of December 31, 2024.